Argos Therapeutics expands board

WORKFLOW SOLUTIONS
PRODUCTS
See More S&P Global Solutions
CONTENT
SECTOR-SPECIFIC INSIGHTS
More ways we can help
NEWS & RESEARCH TOPICS
See More
Featured Events
In PersonPolitics & Policy Live: Trade and Sustainability Amidst Volatile Markets
- 04/04/2023
- Convene, 1201 Wilson Blvd, Arlington, VA 22209
- 3:30 PM – 6:30 PM ET
WebinarThe Private Equity Landscape under review: The Middle East and Africa story in 2023
- 04/05/2023
- Live, Online
- 10:00 am - 11:00 am BST
WebinarManaging Investment Risk Amid Market Uncertainty
- 04/05/2023
- Live, Online
- 11:00 am - 12:00 am EST
PLATFORMS
OTHER PRODUCTS
- Research Online
- 451 Research
See All Product Logins

In This List

Blog

Perspectivas América Latina 2023 Emerging Trends & Growth

Blog

Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in

Blog

A Cloud Migration Plan for Corporations featuring Snowflake®

Blog

Investor Activism Campaigns Hit Record High in 2022

14 Dec, 2016 | 10:32

Author Angelee Tabios
Theme Healthcare & Pharmaceuticals

Argos Therapeutics Inc. added Ralph Snyderman and Irackly Mtibelishvily to its board.

Snyderman is the director of the Duke Center for Research on Personalized Health Care while Mtibelishvily is Citigroup's managing director and chairman of corporate and investment banking in central and eastern Europe, the Middle East and Africa.